0
Finn Sawyer Access to Cancer Testing Act
3/27/2025, 3:07 PM
Summary of Bill HR 1620
One key aspect of the bill is the creation of a new grant program to support research on innovative cancer treatments. This program will provide funding to researchers and organizations working on cutting-edge therapies for cancer, with the goal of accelerating the development of new treatments and improving outcomes for cancer patients.
Additionally, the bill includes measures to improve coordination and communication among researchers, healthcare providers, and government agencies involved in cancer research and treatment. This will help ensure that new discoveries and advancements in cancer treatment are quickly and effectively translated into clinical practice, benefiting patients across the country. Overall, Bill 119 hr 1620 represents a bipartisan effort to address the ongoing challenges in cancer treatment and research. By supporting innovation, collaboration, and access to care, the bill aims to make meaningful progress in the fight against cancer and improve outcomes for patients.
Congressional Summary of HR 1620
Finn Sawyer Access to Cancer Testing Act
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Read the Full Bill
Current Status of Bill HR 1620
Bipartisan Support of Bill HR 1620
Total Number of Sponsors
4Democrat Sponsors
4Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
10Democrat Cosponsors
8Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 1620
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 1620
Comments
Damian Everett
9 months ago
I fully support this bill and believe it is a step in the right direction for advancing cancer treatments. It is crucial that we continue to invest in research and development to find new and improved ways to combat this devastating disease. I am hopeful that this bill will lead to breakthroughs that can benefit not only myself, but countless others who are affected by cancer.
Curtis Stout
8 months ago
This bill is so dumb. It will make things worse for everyone. Short term effects will be chaos.
